Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis.

atrioventricular block cardiac sarcoidosis immunosuppression therapy inflammation

Journal

Journal of arrhythmia
ISSN: 1880-4276
Titre abrégé: J Arrhythm
Pays: Japan
ID NLM: 101263026

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 26 02 2021
revised: 16 05 2021
accepted: 01 06 2021
entrez: 13 8 2021
pubmed: 14 8 2021
medline: 14 8 2021
Statut: epublish

Résumé

Prediction of atrioventricular block (AVB) resolution after steroid therapy in patients with cardiac sarcoidosis (CS) is difficult. We identified 24 patients with CS and complete or advanced AVB receiving steroid therapy. AVB resolution was assessed by reviewing surface electrocardiogram and the percentage of ventricular pacing required on subsequent device interrogation reports. AVB resolution was noted in eight (33%) patients 1 year after receiving steroid therapy. Univariate Cox regression analysis demonstrated that left ventricular ejection fraction (LVEF) (hazard ratio [HR] 1.07, 95% confidence interval [CI] 1.01-1.14, A shorter interval from recognition of AVB to start of steroid therapy, higher LVEF, and higher lysozyme levels were significantly associated with resolution of AVB after steroid therapy in patients with CS. The combination of each variable could be able to distinguish patients with resolution of AVB from those without.

Sections du résumé

BACKGROUND BACKGROUND
Prediction of atrioventricular block (AVB) resolution after steroid therapy in patients with cardiac sarcoidosis (CS) is difficult.
METHODS METHODS
We identified 24 patients with CS and complete or advanced AVB receiving steroid therapy. AVB resolution was assessed by reviewing surface electrocardiogram and the percentage of ventricular pacing required on subsequent device interrogation reports.
RESULTS RESULTS
AVB resolution was noted in eight (33%) patients 1 year after receiving steroid therapy. Univariate Cox regression analysis demonstrated that left ventricular ejection fraction (LVEF) (hazard ratio [HR] 1.07, 95% confidence interval [CI] 1.01-1.14,
CONCLUSIONS CONCLUSIONS
A shorter interval from recognition of AVB to start of steroid therapy, higher LVEF, and higher lysozyme levels were significantly associated with resolution of AVB after steroid therapy in patients with CS. The combination of each variable could be able to distinguish patients with resolution of AVB from those without.

Identifiants

pubmed: 34386137
doi: 10.1002/joa3.12583
pii: JOA312583
pmc: PMC8339084
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1093-1100

Informations de copyright

© 2021 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.

Déclaration de conflit d'intérêts

Authors declare no conflict of interests for this article.

Références

Heart Rhythm. 2007 Oct;4(10):1292-9
pubmed: 17905334
J Cardiovasc Electrophysiol. 2014 Aug;25(8):875-881
pubmed: 24602015
Circulation. 2007 May 15;115(19):2474-80
pubmed: 17470696
Circ Arrhythm Electrophysiol. 2018 Aug;11(8):e006145
pubmed: 30354309
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55
pubmed: 10430755
Int Heart J. 2018 Jul 31;59(4):772-778
pubmed: 29794391
Am J Cardiol. 2001 Nov 1;88(9):1006-10
pubmed: 11703997
N Engl J Med. 1973 Nov 15;289(20):1074-6
pubmed: 4742223
Int J Cardiol. 2017 Jan 15;227:565-570
pubmed: 27836297
Circ Arrhythm Electrophysiol. 2016 Jun;9(6):
pubmed: 27301264
Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1558-66
pubmed: 23715906
Heart Rhythm. 2014 Jul;11(7):1305-23
pubmed: 24819193
Can J Cardiol. 2013 Sep;29(9):1034-41
pubmed: 23623644
Circ Arrhythm Electrophysiol. 2011 Jun;4(3):303-9
pubmed: 21427276
Heart Rhythm. 2015 Dec;12(12):2477-85
pubmed: 26111805
Ann Nucl Med. 2014 May;28(4):393-403
pubmed: 24464391
Circulation. 2015 Feb 17;131(7):624-32
pubmed: 25527698
Circ J. 2019 Oct 25;83(11):2329-2388
pubmed: 31597819
J Am Coll Cardiol. 2016 Jul 26;68(4):411-21
pubmed: 27443438
Circulation. 2002 Mar 5;105(9):1144-5
pubmed: 11877369
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1773-83
pubmed: 21559980
Eur Heart J. 2019 Jun 14;40(23):1862-1869
pubmed: 31155647
Heart Rhythm. 2017 Dec;14(12):1786-1792
pubmed: 28807663
J Cardiol. 2013 Nov;62(5):320-5
pubmed: 24016620

Auteurs

Takeru Nabeta (T)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Masahiko Hara (M)

Center for Community-based Healthcare Research and Education Shimane University Matsue Japan.

Takashi Naruke (T)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Kenji Maemura (K)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Takumi Oki (T)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Mayu Yazaki (M)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Teppei Fujita (T)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Yuki Ikeda (Y)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Shunsuke Ishii (S)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Toshimi Koitabashi (T)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Junya Ako (J)

Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

Classifications MeSH